DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)

Abroad (travel likely)RecruitingPHASE2

Conditions

Glioblastoma (GBM)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Banner MD Anderson Cancer Center, Gilbert, Arizona, United States
Contact: Study coordinator (James Schohn) · James.Schohn@bannerhealth.com · 6025213700
Contact: Principal Investigator (Ramya Tadipatri, MD)
City of Hope, Duarte, California, United States
Contact: Study coordinator (Zorica Simic) · info@coh.org · 6262758069
Contact: Principal Investigator (Jana Portnow, MD)
HOAG, Newport Beach, California, United States
Contact: Study coordinator (Julie Nguyen) · julie.nguyen@hoag.org · 949-764-4577
Contact: Principal Investigator (Simon Khagi, MD)
Baptist MD Anderson Cancer Center, Jacksonville, Florida, United States
Contact: Study coordinator (Andres Alvarez, MD) · CTOinterest@bmcjax.com · 9042027713
Contact: Principal Investigator (Robert Cavaliere, MD)
Cooper University Health Care, Camden, New Jersey, United States
Contact: Study coordinator (Sean Behnke) · Behnke-Sean@CooperHealth.edu · 856-342-2362
Contact: Principal Investigator (Alan Turtz, MD)
Rutgers Cancer Institute, New Brunswick, New Jersey, United States
Contact: Study coordinator (Xiaoru Chen) · xc194@cinj.rutgers.edu · 732-235-2465
Contact: Principal Investigator (Morana Vojnic, MD)
Atlantic Health, Summit, New Jersey, United States
Contact: Study coordinator (Morgan Finlay) · Morgan.finlay@atlantichealth.org · 9085225985
Contact: Principal Investigator (Robert Aiken, MD)
Lenox Hill Hospital, New York, New York, United States
Contact: Study coordinator (Sara Massimo) · smassimo@northwell.edu · 212-434-4482
Contact: Study coordinator (John Boockvar, MD)
UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States
Contact: Study coordinator (Claire Kowalczyk) · cancerclinicaltrials@med.unc.edu · 877-668-0683
Contact: Principal Investigator (Dominique Higgins, MD)
Wake Forest University Health Sciences, Winston-Salem, North Carolina, United States
Contact: Study coordinator (Sara Cox) · sara.cox@advocatehealth.org · 336-713-7748
Contact: Principal Investigator (Roy E Strowd III, MD)
The Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Contact: Study coordinator (Clinical Research Coordinator) · jamesline@osumc.edu · 800-293-5066
Contact: Principal Investigator (J. Bradley Elder, MD)
UPMC Presbyterian Hospital, Pittsburgh, Pennsylvania, United States
Contact: Study coordinator (Theodore Estep) · esteptj2@upmc.edu · 878-261-6727
Contact: Principal Investigator (Costas Hadjipanayis, MS, MD, PhD)
Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, United States
Contact: Study coordinator (Kathy Taylor) · kathy.l.taylor@vumc.org · 615-875-0060
Contact: Principal Investigator (Ryan Merrell, MD)
UTHealth Houston, Houston, Texas, United States
Contact: Study coordinator (Mia Vu) · mia.vu@uth.tmc.edu · 7134868000
Contact: Principal Investigator (Nitin Tandon, MD)
Baylor College of Medicine, Houston, Texas, United States
Contact: Study coordinator (Glenn Wilson) · ggwilson@bcm.edu · 713-798-2273
Contact: Principal Investigator (Jacob Mandel, MD)
The University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States
Contact: Study coordinator (Leti Velten, RN) · Velten@uthscsa.edu · 210-450-1921
Contact: Principal Investigator (Andrew Brenner, MD, PhD)

View source on ClinicalTrials.gov